E-mail this page Printer Friendly Version RSS E-mail Alerts View contacts Download Financial Tear Sheet 

Investor Relations

DGX (Common Stock)
ExchangeNYSE (US Dollar)
Price$60.32
Change (%) Stock is Down 0.36 (0.59%)
Intraday High$61.16
Intraday Low$60.25
Volume930,647
Data as of 10/01/14 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Headlines More >
TitleDate
Quest Diagnostics Names Mayo Clinic Executive Franklin R. Cockerill, M.D., Vice President and Chief Laboratory Officer
Former president and CEO of Mayo Medical Laboratories and chair of lab medicine and pathology for Mayo Clinic to oversee Quest's clinical testing operations MADISON, N.J., Oct. 1, 2014 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that Franklin R. Cockerill, III, M.D., has joined the company as vice president and chief laboratory officer, effective October 1, 2014. Dr. Cockerill w... 
10/01/14
Quest Diagnostics To Host Investor Day On November 5, 2014
MADISON, N.J., Oct. 1, 2014 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the  world's leading provider of diagnostic testing, information and services, will host Investor Day for institutional investors and financial analysts in New York City on Wednesday, November 5, 2014 at The Hudson Theatre at the Millennium Broadway, 145 West 44th Street, New York, NY.  During the event, Quest Diagnostics executives will discuss the company's strategy, performance and plans to drive s... 
10/01/14
Quest Diagnostics Marks 10 Years on the Dow Jones Sustainability Index
MADISON, N.J., Sept. 12, 2014 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today celebrates a decade on the North America Dow Jones Sustainability Index (DJSI) and 11 consecutive years on the World DJSI. The Dow Jones Sustainability Index family ranks companies for corporate sustainability according to economic, environmental and social criteria. To be included or remain in the index, companies must continually intensify th... 
09/12/14
Workforce Drug Test Positivity Rate Increases for the First Time in 10 Years, Driven by Marijuana and Amphetamines, Finds Quest Diagnostics Drug Testing Index™ Analysis of Employment Drug Tests
Colorado and Washington experience surges in marijuana tests positivity rate, but data suggests state legalization of recreational marijuana may not be sole driver of increases MADISON, N.J., Sept. 11, 2014 /PRNewswire/ -- The percentage of positive drug tests among American workers has increased for the first time in more than a decade, fueled by a rise in marijuana and amphetamines, according to an analysis of 8.5 million urine, oral fluid and hair workplace drug test results released tod... 
09/11/14
Upcoming EventsMore >
DateTitle
10/23/14
Q3 2014 Quest Diagnostics Earnings Release
10/23/14
Q3 2014 Quest Diagnostics Earnings Conference Call
Contact Us:
Dan Haemmerle
Executive Director Investor Relations
973-520-2900
Investor@QuestDiagnostics.com

Company Calendar
October 2014?
Calendar Help
This calendar contains six months of past and future company related information, which may include press releases, SEC filings, calendar events and more. Dates containing information are indicated by a colored background. You may hover your mouse over a date that contains an event to reveal the event or events taking place on that day including a link to additional information. This calendar requires JavaScript to be installed and activated on your browser.
Calendar Icon Legend:
Analyst Meeting
Conference
Conference Presentation
Corporate Conference Call
Custom Events
Earnings Conference Call
Earnings Release
Financial Reports
Mergers & Acquisition Announcement
Guidance Announcement
Other Corporate
Sales Call/Presentation
Sales Release
Shareholders Meeting
News Release
SEC Filings
Presentations
52 Week High
Today
SunMonTueWedThuFriSat
-3-2-11234
567891011
12131415161718
1920212223
10/23/14
Q3 2014 Quest Diagnostics Earnings Release
8:30 a.m. ET
Q3 2014 Quest Diagnostics Earnings Conference Call
2425
26272829303151

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.